SLC6A3 and attention deficit-hyperactivity disorder: Their study reports that mice that were exposed to deltamethrin, a pyrethroid compound, during development showed several features of attention deficit hyperactivity disorder (ADHD), that is, elevated dopamine transporter level, hyperactivity, working memory and attention deficits, and impulsivity.